Retour
Prix MoonLake Immunotherapeutics (MLTX)
Graphique du cours de l'action MLTX
MLTX Gagner
MoonLake Immunotherapeutics
$16.76
2.5%
$0.41
À la fermeture : Jan 16, 16:00:00 GMT-5
$16.75
-0.05%
$-0.01
Post-Marché: Jan 16, 20:00:00 GMT-5
Statistiques clés
Clôture préc.
$16.35
Prix d'ouverture
$16.39
Plage de la journée
$16.18 - $16.88
Plage de 52 semaines
$5.95 - $62.75
Volume
1.4M
Volume moyen
4.5M
BPA (TTM)
-3.33
Rendement en dividend
--
Capitalisation boursière
$1.2B
Qu’est-ce que MLTX ?
Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. The company is headquartered in Zug, Zug and currently employs 100 full-time employees. The company went IPO on 2020-10-20. The Firm is a clinical-stage biopharmaceutical company focused on the development of medicines for immunologic diseases, including inflammatory skin and joint diseases. The firm develops tri-specific nanobody Sonelokimab (SLK) which purpose is to target and penetrate difficult-to-reach inflamed tissues. SLK is a molecule with enhanced enrichment in deep skin & joints and binding of targets. SLK inhibits IL-17A and IL-17F inhibition to treat inflammatory diseases, by independently inhibiting the naturally-occurring IL-17 A/A, A/F and F/F dimers that drive inflammation in patients.
Fonctionnalités
Stratégies de trading
Ressources
© 2025 Finture Development Limited. All rights reserved